Neuralink’s Brain Implant Sees New Clinical Trials

|June 22, 2024|
SHARE
Neuralink’s Brain Implant Sees New Clinical Trials, Technology News, Business Ideas, and Digital Trends

Neuralink, Elon Musk’s brain-machine interface company, has announced a new phase of clinical trials for its brain implants. The trials aim to explore the potential of these implants to restore vision and motor functions in individuals with severe neurological conditions. This development follows previous successful trials and represents a significant step towards the broader application of neural interfaces in medical treatments. The technology involves implanting tiny electrodes in the brain, capable of interpreting neural signals and translating them into commands for external devices.

Related